Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.78
-0.03 (-0.44%)
At close: Aug 19, 2025, 11:51 AM
Day One Biopharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 187.64M | 161.92M | 131.16M | 102.51M | 8.75M | 560K | 560K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 11.22M | 8.16M | 5.39M | 2.69M | 1.2M | 587K | 560K | 460K | 526K | 434K | 345K | 165K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 176.42M | 153.76M | 125.77M | 99.82M | 7.55M | -27K | n/a | -460K | -526K | -434K | -345K | -165K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -111.74M | -191.57M | -217.27M | -211.46M | -292.53M | -226.98M | -206.06M | -189.29M | -177.55M | -165.02M | -146.91M | -226.1M | -205.64M | -184.36M | -172.7M | -56.91M | -41.23M | -28.1M |
Interest Income | 21.14M | 20.43M | 15.34M | 9.28M | 9.25M | 8.7M | 8.7M | 11.36M | 7.96M | 4.55M | 4.55M | 1.9M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -89.4M | -61.94M | -88.35M | -83.62M | -165.93M | -208.94M | -188.92M | -174.51M | -166.16M | -156.83M | -142.18M | -221.9M | -203.34M | -182.28M | -170.64M | -86.41M | -71.02M | -57.95M |
Net Income | -95M | -69.08M | -95.5M | -84.29M | -167.48M | -208.94M | -181.9M | -162.2M | -150.05M | -140.72M | -133.09M | -218.1M | -203.34M | -181.09M | -168.53M | -83.08M | -66.67M | -54.14M |
Selling & General & Admin | 117M | 118.22M | 115.33M | 107.77M | 97.07M | 83.96M | 75.54M | 70.1M | 69.49M | 66.57M | 61.29M | 73.73M | 65.45M | 56.82M | 47.53M | 20.35M | 11.98M | 7.33M |
Research & Development | 171.15M | 227.11M | 227.7M | 203.23M | 202.83M | 142.9M | 130.52M | 119.19M | 108.06M | 98.44M | 85.62M | 103.18M | 91M | 78.35M | 75.98M | 36.56M | 29.25M | 20.77M |
Other Expenses | n/a | n/a | -10K | -28K | -31K | -46K | -40K | -48K | -36K | -21K | -18K | 22K | 20K | -7K | -14K | -54K | -62K | -35K |
Operating Expenses | 288.15M | 345.33M | 343.04M | 311M | 299.9M | 226.86M | 206.06M | 189.29M | 177.55M | 165.02M | 146.91M | 176.91M | 156.45M | 135.17M | 123.51M | 56.91M | 41.23M | 28.1M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.66M | 2.66M | 2.66M | 2.66M | 6K | 12K | 19K | 24K | 28K | 31K | 34K |
Selling & Marketing Expenses | -1.82M | -1.82M | -1.93M | -116K | -116K | -116K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 299.38M | 353.49M | 348.43M | 313.41M | 300.72M | 226.98M | 206.06M | 189.29M | 177.55M | 165.02M | 146.91M | 176.91M | 156.45M | 135.17M | 123.51M | 56.91M | 41.23M | 28.1M |
Income Tax Expense | 5.59M | 7.14M | 7.22M | 742.72K | 1.53M | -26.28K | -7.12M | -12.41M | -16.11M | -16.3M | -9.29M | -3.99M | -181K | -19K | -16K | -20K | -27K | n/a |
Shares Outstanding (Basic) | 103.07M | 102.71M | 93.62M | 96.62M | 87.12M | 86.68M | 87.23M | 85.95M | 74.96M | 71.97M | 73.46M | 71.01M | 60.76M | 58.38M | 61.95M | 61.93M | 61.93M | 61.93M |
Shares Outstanding (Diluted) | 103.07M | 102.71M | 93.62M | 96.94M | 87.12M | 86.68M | 87.23M | 85.95M | 74.96M | 71.97M | 73.46M | 71.01M | 60.76M | 58.38M | 61.95M | 61.93M | 61.93M | 61.93M |
EPS (Basic) | -0.96 | -0.72 | -1.09 | -1.01 | -1.93 | -2.49 | -2.26 | -2.11 | -2.05 | -2.04 | -2.03 | -3.49 | -3.32 | -2.95 | -2.72 | -1.35 | -1.09 | -0.88 |
EPS (Diluted) | -0.96 | -0.72 | -1.09 | -1.01 | -1.93 | -2.49 | -2.26 | -2.11 | -2.05 | -2.04 | -2.03 | -3.49 | -3.32 | -2.95 | -2.72 | -1.35 | -1.09 | -0.88 |
EBITDA | -110.08M | -189.6M | -216.2M | -211.13M | -292.2M | -226.96M | -206.05M | -189.28M | -177.54M | -164.87M | -146.76M | -126M | -105.49M | -84.29M | -72.59M | -86.16M | -70.77M | -57.73M |
EBIT | -107.08M | -191.57M | -217.27M | -211.46M | -292.53M | -226.98M | -206.06M | -189.29M | -177.55M | -165.02M | -146.91M | -126.11M | -105.65M | -84.37M | -72.7M | -86.35M | -70.95M | -57.91M |
Depreciation & Amortization | 3.36M | 2.81M | 2.03M | 1.37M | 726K | 410K | 383K | 460K | 526K | 567K | 531K | 356K | 241K | 157K | 153K | 197K | 193K | 190K |